US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

202.40

+0.40000.20%

Post-market: 202.10-0.2992-0.15%18:54 EDT

Volume:1.10M

Turnover:222.81M

Market Cap:10.31B

PE:32.07

High:204.16

Open:202.49

Low:200.98

Close:202.00

52wk High:217.12

52wk Low:138.79

Shares:50.95M

Float Shares:50.95M

Volume Ratio:0.64

T/O Rate:2.16%

Dividend:0.40

Dividend Rate:0.20%

EPS(TTM):6.31

EPS(LYR):35.34

ROE:24.54%

ROA:0.10%

PB:1.27

PE(LYR):5.73

Loading ...

Overview Company News Filings

Amgen’s Phase 3 Dazodalibep Study Nears Data Spotlight for Sjögren’s Investors

Roche, GSK's Lung-Cancer Drug Candidates Show Promise in China

Biofrontera announces FDA approval of Ameluz supplemental new drug application

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday Amid AI Pullback

MT Newswires Live

Sector Update: Healthcare Stocks Rise Premarket Monday

MT Newswires Live

FDA Approves Shorter Monitoring Time for Amgen’s Imdelltra First Two Doses

Amgen - Imdelltra Monitoring Reduced to 6-8 Hours for First Two Infusions

THOMSON REUTERS

Amgen - Imdelltra Monitoring Remains 6-8 Hours for Third Dose, 3-4 Hours for Cycles 3-4

THOMSON REUTERS

FDA Approves Reduced Monitoring Time for First Two Doses of Imdelltra®

THOMSON REUTERS

Amgen - Patients to Receive Follow-up Assessment After First Two Imdelltra Doses

THOMSON REUTERS

Scholar Rock Wins FDA Approval for SMA Therapy

Cabaletta Bio Boosts Cash Through Warrant Exercises

Scholar Rock price target raised to $84 from $76 at BMO Capital

Sino Biopharmaceutical Stock Advances 4.3% in Hong Kong, Outperforms Competitors

Vertex Minerals Revises Timeline for Proposed Securities Issue

Telix Wins FDA Nod for First FET-PET Glioma Imaging Drug Pixclara

Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street

Palo Alto, Eaton, Amgen, SpaceX, LMT Trending With Analysts

Scholar Rock announces FDA approval of isembyld

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/IBB/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"iShares Biotechnology ETF","latestPrice":202.4,"timestamp":1789588800000,"preClose":202,"halted":0,"volume":1098688,"hourTrading":{"tag":"盘后","latestPrice":202.1008,"preClose":202.4,"latestTime":"18:54 EDT","volume":1053,"amount":213304.23036,"timestamp":1789599269703,"change":-0.2992,"changeRate":-0.001478,"amplitude":0.009733},"delay":0,"changeRate":0.0019801980198020084,"floatShares":50950000,"shares":50950000,"eps":6.311863,"marketStatus":"Post-Mkt","change":0.4,"latestTime":"09-16 19:16:45 EDT","open":202.49,"high":204.1599,"low":200.98,"amount":222812454.15808,"amplitude":0.015742,"askPrice":203.06,"askSize":10,"bidPrice":202,"bidSize":300,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":202,"sharesOutstanding":49450000,"nav":204.610559,"aum":10516982732.6,"dividendRate":0.001996,"bidAskSpread":0.000306,"preHourTrading":{"tag":"盘前","latestPrice":203.71,"preClose":202,"latestTime":"09:17 EDT","volume":108,"amount":21996.522,"timestamp":1789564649878,"change":1.71,"changeRate":0.008465,"amplitude":0.010149},"postHourTrading":{"tag":"盘后","latestPrice":202.1008,"preClose":202.4,"latestTime":"18:54 EDT","volume":1053,"amount":213304.23036,"timestamp":1789599269703,"change":-0.2992,"changeRate":-0.001478,"amplitude":0.009733},"volumeRatio":0.643023,"impliedVol":0.2493,"impliedVolPercentile":0.745},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":50950000,"roa":"0.10%","roe":"24.54%","lyrEps":35.344796,"volumeRatio":0.643023,"shares":50950000,"dividePrice":0.404,"high":204.1599,"amplitude":0.015742,"preClose":202,"low":200.98,"week52Low":138.785,"pbRate":"1.27","psRate":"248.11","week52High":217.12,"institutionHeld":0,"latestPrice":202.4,"committee":0.935484,"eps":6.311863,"divideRate":0.001996,"volume":1098688,"delay":0,"ttmEps":6.311863,"open":202.49,"prevYearClose":168.77,"prevWeekClose":202.93,"prevMonthClose":209.05,"prevQuarterClose":190.19,"fiveDayClose":205.49,"twentyDayClose":203.56,"sixtyDayClose":177},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-09-15","symbol":"IBB","amount":0.011194,"announcedDate":"2026-09-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-15","defaultRemindTime":1789479000000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-09-15","currency":"USD","dateTimestamp":1789444800000,"payDate":"2026-09-18"},{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.0858219,"currency":"USD"},{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667667070","title":"Amgen’s Phase 3 Dazodalibep Study Nears Data Spotlight for Sjögren’s Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2667667070","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667667070?lang=en_us&edition=fundamental","pubTime":"2026-09-15 00:30","pubTimestamp":1789403411,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. The phase 3 study A Phase 3 Randomized, Double-blind, Placebo-controlled Stu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-phase-3-dazodalibep-study-nears-data-spotlight-for-sjogrens-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-phase-3-dazodalibep-study-nears-data-spotlight-for-sjogrens-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIB","BK4211","LU2112291526.USD","LU1057294990.SGD","PJP","BK4588","SG9999001440.SGD","IBB","BK4533","LU0320765992.SGD","BBH","BK4534","LU1571399168.USD","LU1061106388.HKD","BK4566","LU0868494617.USD","LU1023059063.AUD","IE00BJT1NW94.SGD","BK4581","LU2242652126.USD","IE00BJJMRZ35.SGD","ISBC","IE00B2B36J28.USD","LU0289739699.SGD","BK4139","LU1983299246.USD","IE0002141913.USD","LU0058720904.USD","LU2468319806.SGD","LU2089984988.USD","TBXU","AMGN","BK4585","LU0889565916.HKD","IE0009355771.USD","LU0109394709.USD","PBE","LU0122379950.USD","IE00BFTCPJ56.SGD","BK4599","IBBQ","LU2242646821.SGD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667661729","title":"Roche, GSK's Lung-Cancer Drug Candidates Show Promise in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2667661729","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667661729?lang=en_us&edition=fundamental","pubTime":"2026-09-14 22:04","pubTimestamp":1789394640,"startTime":"0","endTime":"0","summary":"1404 GMT - Roche Holding and GSK's Chinese partners reported strong clinical-trial data for their respective lung-cancer drug candidates in China-only clinical trials, analysts at J.P. Morgan write in a research note. Both drugs, one from GSK and partner Hansoh Pharmaceutical and another from Roche and MediLink, showed a 54% improvement in overall survival rates in the trials. This seems competitive relative to a 40% benefit shown by Amgen's Imdelltra in a global trial, the analysts say. Roche and MediLink's candidate tam-peli has a better tolerability profile than GSK and Hansoh's ris-rez, they add. Ris-rez has better median overall-survival data, but it will be important to confirm this result in a global trial, according to JPM. GSK shares rise 4.6% and Roche's jump 5.7%, while Hansoh's close 5.1% higher.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PJP","SG9999001440.SGD","LU0868494617.USD","LU0320765992.SGD","LU1057294990.SGD","IE00B2B36J28.USD","CANC","IBBQ","LU2242652126.USD","LU2112291526.USD","HRTS","IE0002141913.USD","TBXU","03692","RHHBY","BK1589","IBB","LU2089984988.USD","BK4566","BBH","LU1983299246.USD","LU1571399168.USD","LU0109394709.USD","PBE","LU2468319806.SGD","BK4007","IE00BJJMRZ35.SGD","BK4581","AMGN","BIB","GSK","IE00B4R5TH58.HKD","BK4599","IE00BJT1NW94.SGD","LU0122379950.USD","GSKH","LU0289739699.SGD","BK4532","LU0058720904.USD","LU1061106388.HKD","BK1191","LU1829250122.USD","03165","BK4534","LU1023059063.AUD","BK4533","LU0889565916.HKD","IE0009355771.USD","GSK.UK","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667661630","title":"Biofrontera announces FDA approval of Ameluz supplemental new drug application","url":"https://stock-news.laohu8.com/highlight/detail?id=2667661630","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667661630?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:35","pubTimestamp":1789392922,"startTime":"0","endTime":"0","summary":"Biofrontera (BFRI) announced that the FDA has approved the company’s supplemental new drug application, or sNDA, for Ameluz topical gel, 10%, in co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDI","MRNY","IEIH","LABU","GNMX","TECB","IYH","GDOC","BK4007","PSCH","PINK","SYNB","BFRI","NVIB","LFSC","BMED","TBXU","IDNA","BK4585","BBP","MRNX","XLVX","RSPH","BK4588","FRTY","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667669144","title":"Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday Amid AI Pullback","url":"https://stock-news.laohu8.com/highlight/detail?id=2667669144","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667669144?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:20","pubTimestamp":1789392016,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.6%, and the actively traded Invesco QQQ Trust (QQQ) was 1.5% lower in Monday's premarket activity as warnings from AI indu","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XLE","QQQ","IBB","SLV","XLK","FAS","QTOC","BWIN","UNG","ARTY","CHAT","SRRK","KVUE","BETH","ESTC","GLD","AIPO","OXY","EQR","VDC","AGIX","RTH","IGM","SOXX","EETH","XLI","XLV","KMB","SPY","SPCX","FAZ","BITO","VHT","IYH","NVDA","IYK","USO","RTH.AU","XLP","VIS","IYJ","XLY","XLF","XRT","XSD","VTHR","IYW","IYE","VHT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667970669","title":"Sector Update: Healthcare Stocks Rise Premarket Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2667970669","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667970669?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:17","pubTimestamp":1789391865,"startTime":"0","endTime":"0","summary":"Healthcare stocks were rising premarket Monday, with the State Street Health Care Select Sector SPDR ETF  advancing by 1.2% and the iShares Biotechnology ETF  0.3% higher.GSK  licensor Hansoh Pharmaceutical reported that a phase 3 trial evaluating risvutatug rezetecan, or Ris-Rez, against commonly used topotecan in patients with relapsed small-cell lung cancer met its primary endpoint. GSK stock was up more than 4% pre-bell.Astrazeneca  shares were up more than 2% after the company said a late-stage study of its drug Enhertu showed a six-month improvement in median progression-free survival as a first-line treatment for advanced HER2-mutant non-small cell lung cancer.Johnson & Johnson  stock was up more than 1% after the company said a phase 3 trial of its lung cancer drug Rybrevant combined with chemotherapy resulted in a median overall survival of 34.3 months. Separately, The Wall Street Journal reported that Apollo Global Management  is in talks to acquire Johnson & Johnson's hips-a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GSK.UK","LU1280957306.USD","SGXZ80539844.SGD","IYH","LU0053666078.USD","IE00BSNM7G36.USD","BMED","IBB","LU2213496289.HKD","LU0069063385.USD","LU0210536198.USD","LU0912757837.SGD","APO","PJP","FHLC","AZN","JNJ","LU1228905037.USD","HCSG","LU2750360641.GBP","PRVT","XLV","LU2133065610.SGD","IE00B4R5TH58.HKD","MEDX","LU1043141123.HKD","TRUH","LU1935042991.SGD","AAUM","GSKH","FTXH","GDOC","GSK","LABU","AZNH","IHE","RXL","BK4550","LU0289739699.SGD","VHT","XBI","LU2471134796.USD","GPZ","JDOC","LU0203347892.USD","LU1244550577.SGD","LBO","LU1718418525.SGD","IXJ","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667669562","title":"FDA Approves Shorter Monitoring Time for Amgen’s Imdelltra First Two Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=2667669562","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667669562?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:06","pubTimestamp":1789391173,"startTime":"0","endTime":"0","summary":"FDA approves shorter monitoring time for Amgen’s Imdelltra first two dosesFDA cleared a label update for Amgen’s IMDELLTRA that cuts post-infusion monitoring for the first two doses to 6-8 hours.Prior","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDLtJX3g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","LU0109394709.USD","LU0058720904.USD","LU2242652126.USD","SG9999001440.SGD","PJP","IBB","BK4566","LU2112291526.USD","BK4139","LU2242646821.SGD","BK4599","LU1023059063.AUD","BK4533","LU0320765992.SGD","LU1983299246.USD","PBE","LU0889565916.HKD","BIB","TBXU","LU0289739699.SGD","LU1061106388.HKD","BK4534","AMGN","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BK4585","LU2468319806.SGD","IBBQ","BBH","BK4588","IE0009355771.USD","LU0868494617.USD","LU1571399168.USD","IE00BJT1NW94.SGD","LU0122379950.USD","BK4581","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU1057294990.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667778666","title":"Amgen - Imdelltra Monitoring Reduced to 6-8 Hours for First Two Infusions","url":"https://stock-news.laohu8.com/highlight/detail?id=2667778666","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667778666?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:00","pubTimestamp":1789390805,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUA41PDLW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1023059063.AUD","LU2242652126.USD","PJP","BK4533","LU1061106388.HKD","BK4139","LU0289739699.SGD","LU0122379950.USD","TBXU","SG9999001440.SGD","AMGN","BK4588","IE00BJJMRZ35.SGD","LU0058720904.USD","IE0009355771.USD","BK4534","LU1571399168.USD","PBE","IE00B4R5TH58.HKD","IE00B2B36J28.USD","IBB","LU0889565916.HKD","BK4581","LU2112291526.USD","IE00BJT1NW94.SGD","LU1057294990.SGD","BK4566","BK4585","BIB","LU0109394709.USD","IBBQ","BK4599","BBH","LU2468319806.SGD","LU2089984988.USD","IE0002141913.USD","LU0868494617.USD","LU1983299246.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD","LU2242646821.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667774666","title":"Amgen - Imdelltra Monitoring Remains 6-8 Hours for Third Dose, 3-4 Hours for Cycles 3-4","url":"https://stock-news.laohu8.com/highlight/detail?id=2667774666","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667774666?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:00","pubTimestamp":1789390805,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUA41PDLW:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2089984988.USD","LU1061106388.HKD","LU2242646821.SGD","LU2112291526.USD","BK4588","BK4599","IE00BJJMRZ35.SGD","LU0122379950.USD","IE00B4R5TH58.HKD","BK4585","IBB","LU2242652126.USD","BK4581","PBE","LU0058720904.USD","LU1057294990.SGD","IE00BFTCPJ56.SGD","LU0889565916.HKD","LU1571399168.USD","LU1983299246.USD","LU2468319806.SGD","BBH","IBBQ","BK4566","BIB","LU0109394709.USD","BK4533","IE00BJT1NW94.SGD","IE00B2B36J28.USD","PJP","TBXU","LU0868494617.USD","AMGN","LU0289739699.SGD","LU1023059063.AUD","IE0002141913.USD","BK4534","IE0009355771.USD","LU0320765992.SGD","SG9999001440.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667701666","title":"FDA Approves Reduced Monitoring Time for First Two Doses of Imdelltra®","url":"https://stock-news.laohu8.com/highlight/detail?id=2667701666","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667701666?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:00","pubTimestamp":1789390805,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUA41PDLW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4533","LU2089984988.USD","LU2242652126.USD","BK4585","LU0122379950.USD","LU2242646821.SGD","PJP","LU1023059063.AUD","LU1061106388.HKD","IBBQ","IE0002141913.USD","LU0289739699.SGD","LU1983299246.USD","TBXU","BK4534","AMGN","IE00BFTCPJ56.SGD","PBE","LU1057294990.SGD","IBB","BBH","LU2112291526.USD","LU0889565916.HKD","BK4588","LU0058720904.USD","BIB","LU0109394709.USD","LU1571399168.USD","IE00B4R5TH58.HKD","LU0868494617.USD","IE00BJJMRZ35.SGD","LU0320765992.SGD","BK4139","IE00BJT1NW94.SGD","IE0009355771.USD","BK4566","BK4599","LU2468319806.SGD","IE00B2B36J28.USD","BK4581","SG9999001440.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667082666","title":"Amgen - Patients to Receive Follow-up Assessment After First Two Imdelltra Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=2667082666","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667082666?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:00","pubTimestamp":1789390805,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUA41PDLW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIB","SG9999001440.SGD","IE0002141913.USD","BK4139","BK4585","LU2468319806.SGD","IBB","LU2089984988.USD","IE00BJT1NW94.SGD","TBXU","BK4581","LU0868494617.USD","IE00BFTCPJ56.SGD","PJP","BK4566","BK4588","IE00B4R5TH58.HKD","BK4599","BBH","LU1057294990.SGD","LU2242652126.USD","LU0889565916.HKD","IBBQ","LU0109394709.USD","BK4534","IE00B2B36J28.USD","PBE","LU0320765992.SGD","LU1571399168.USD","BK4533","LU1023059063.AUD","LU2112291526.USD","LU0289739699.SGD","LU2242646821.SGD","LU1983299246.USD","LU0058720904.USD","LU0122379950.USD","LU1061106388.HKD","IE00BJJMRZ35.SGD","AMGN","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667066661","title":"Scholar Rock Wins FDA Approval for SMA Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2667066661","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667066661?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:32","pubTimestamp":1789389127,"startTime":"0","endTime":"0","summary":"The latest update is out from Scholar Rock Holding ( ($SRRK) ). On September 11, 2026, Scholar Rock announced U.S. FDA approval of ISEMBYLD (apiteg...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/scholar-rock-wins-fda-approval-for-sma-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/scholar-rock-wins-fda-approval-for-sma-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMED","MRNY","LFSC","LABU","PSCH","NVIB","IEIH","MRNX","XLVX","BBP","BK4585","GNMX","PINK","GDOC","SYNB","IBB","RSPH","IDNA","TBXU","TECB","IYH","BK4588","MEDI","FRTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667666613","title":"Cabaletta Bio Boosts Cash Through Warrant Exercises","url":"https://stock-news.laohu8.com/highlight/detail?id=2667666613","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667666613?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:31","pubTimestamp":1789389071,"startTime":"0","endTime":"0","summary":"Cabaletta Bio ( ($CABA) ) has provided an update. Cabaletta Bio, a biotechnology company developing engineered immune cell therapies for autoimmune...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cabaletta-bio-boosts-cash-through-warrant-exercises?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cabaletta-bio-boosts-cash-through-warrant-exercises?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4139","SYNB","BK4588","AGNG","LNGR","BBP","RSPH","FHLC","FWD","XT","JDOC","IBB","CABA","IEIH","DARP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667134663","title":"Scholar Rock price target raised to $84 from $76 at BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2667134663","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667134663?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:36","pubTimestamp":1789385772,"startTime":"0","endTime":"0","summary":"BMO Capital raised the firm’s price target on Scholar Rock (SRRK) to $84 from $76 and keeps an Outperform rating on the shares. The FDA approval of...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","IBB","SRRK","LFSC","GDOC","GNMX","IBRN","XLVX","FRTY","IDNA","LABU","MEDI","BK4139","THNR","NVIB","MRNX","TBXU","BK4585","IYH","PINK","SYNB","RSPH","BMED","BBP","MRNY","PSCH","IEIH","TECB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667659991","title":"Sino Biopharmaceutical Stock Advances 4.3% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2667659991","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667659991?lang=en_us&edition=fundamental","pubTime":"2026-09-14 16:30","pubTimestamp":1789374600,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. advanced 4.3% to 5.48 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.5% to 24917.60.The stock's rise snapped a three-day losing streak.Sino Biopharmaceutical Ltd. closed 38% below its 52-week high of HK$8.86, which the company achieved Sept. 15.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 1.8% and Amgen Inc. remained unchanged.Trading volume totaled 72.9 million shares, compared to the 50-day average of 98.8 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","LU2112291526.USD","BK1515","PBE","LU1571399168.USD","BK4139","01177","LU2089984988.USD","BK1589","IE0009355771.USD","BK4585","LU0868494617.USD","LU0289739699.SGD","TBXU","BK4533","IE00BZ08YR35.GBP","LU0122379950.USD","BK1521","BK4588","IBB","BK4599","PJP","LU2468319806.SGD","SG9999001440.SGD","LU1057294990.SGD","AMGN","LU1061106388.HKD","LU1023059063.AUD","IE00B4R5TH58.HKD","LU0058720904.USD","IBBQ","IE00BJJMRZ35.SGD","IE00BZ08YS42.EUR","BK4581","BIB","IE00BZ08YT58.USD","BK1191","LU2242652126.USD","LU0320765992.SGD","IE0002141913.USD","BBH","LU0109394709.USD","LU1983299246.USD","IE00B2B36J28.USD","LU0889565916.HKD","BK4534","LU2242646821.SGD","HK0000165453.HKD","IE00BJT1NW94.SGD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667635488","title":"Vertex Minerals Revises Timeline for Proposed Securities Issue","url":"https://stock-news.laohu8.com/highlight/detail?id=2667635488","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667635488?lang=en_us&edition=fundamental","pubTime":"2026-09-14 07:40","pubTimestamp":1789342824,"startTime":"0","endTime":"0","summary":"Vertex Minerals Ltd. ( ($AU:VTX) ) has provided an update. Vertex Minerals Ltd. has updated its proposed securities placement timetable, revising t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-revises-timeline-for-proposed-securities-issue?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-revises-timeline-for-proposed-securities-issue?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","BK4533","BK4588","LU0566484027.USD","VRTX","LU0432979614.USD","LU2089984988.USD","SG9999001176.SGD","BK4109","IE00B4R5TH58.HKD","LU0058720904.USD","IBBQ","SGXZ57979304.SGD","LU0889565916.HKD","MTX","LU1559883803.SGD","BK4585","LU1093756325.SGD","IDNA","IE00BJT1NW94.SGD","IE00B19Z9P08.USD","LU1674673428.USD","LU1674673691.USD","BK4532","PBE","IE00BJJMRZ35.SGD","IE00B894F039.SGD","LU0079474960.USD","LU0234570918.USD","LU2362541273.HKD","LU1430594728.SGD","IE00BZ9MQY76.HKD","VERX","IE00B2B36J28.USD","LU0061475181.USD","LU1815336091.USD","LU0417517546.SGD","LU0256863811.USD","IE0009355771.USD","BBH","LU2462157665.USD","LU1585245621.USD","TBXU","GNMX","LU2468319806.SGD","LU0757428866.USD","BIB","SG9999001176.USD","IBB","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667635862","title":"Telix Wins FDA Nod for First FET-PET Glioma Imaging Drug Pixclara","url":"https://stock-news.laohu8.com/highlight/detail?id=2667635862","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667635862?lang=en_us&edition=fundamental","pubTime":"2026-09-14 06:54","pubTimestamp":1789340092,"startTime":"0","endTime":"0","summary":"The latest update is out from Telix Pharmaceuticals ( ($AU:TLX) ). Telix Pharmaceuticals has secured U.S. FDA approval for Pixclara, the first FET-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-nod-for-first-fet-pet-glioma-imaging-drug-pixclara?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-nod-for-first-fet-pet-glioma-imaging-drug-pixclara?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP","BK4588","MRNY","IEIH","IYH","BMED","TECB","BK4179","BK4585","IDNA","MRNX","XLVX","LABU","PINK","LFSC","NVIB","TLX","MEDI","PSCH","GDOC","GNMX","RSPH","FET","BK4139","IBB","TBXU","SYNB","FRTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666509524","title":"Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2666509524","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666509524?lang=en_us&edition=fundamental","pubTime":"2026-09-12 17:30","pubTimestamp":1789205400,"startTime":"0","endTime":"0","summary":"There is a strange paradox haunting healthcare investing right now.Heart disease remains humanity's top killer, yet for drugmakers and Wall Street, it is becoming one of the hardest places to make mon","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064131342.USD","BK4534","LU1868836757.USD","LU2237443895.HKD","LU2324357040.USD","LU0203201768.USD","LU1145028129.USD","LLII","THNR","IE00BFSS7M15.SGD","LU2750360997.AUD","IE00B1XK9C88.USD","LU0106261372.USD","LU2756315664.SGD","LU0225283273.USD","PBE","BK4585","LU1868836591.USD","BBH","LU2746668974.SGD","AGNG","LU0823434740.USD","SG9999001440.SGD","SG9999015945.SGD","LU2468319806.SGD","JDOC","LU2111349929.HKD","LU2237443465.HKD","LU1291159041.SGD","BK4578","LU2471134952.CNY","NVS","LU2750360641.GBP","SG9999018857.SGD","LU0079474960.USD","ELIL","LU1548497426.USD","LU2168564495.EUR","LU1023059063.AUD","LU1057294990.SGD","LU2237443382.USD","LU0210536198.USD","LU1989771016.USD","LU1868837300.USD","LU2237443549.SGD","LU0466842654.USD","IE00B7KXQ091.USD","LU0943347566.SGD","LU0320765059.SGD","MEDX","LU0683600562.USD","LU2237443622.USD","LU2361044865.SGD","LU0316494557.USD","LU2063271972.USD","LU2552382215.SGD","LU0061475181.USD","LU0868494617.USD","LU1127390331.HKD","LU0471298694.HKD","LU0174119429.USD","LU1691799644.USD","LU0456855351.SGD","VHT","NVOX","LU0323591593.USD","LU2491049909.HKD","LU1061106388.HKD","SG9999014898.SGD","IE00BWXC8680.SGD","LU0353189680.USD","04332","LU0114720955.EUR","LU0385154629.USD","LU2168564065.EUR","IE0001KFT4U8.USD","LU1551013342.USD","LU2456880835.USD","NVO","TMED","LU2360106947.USD","LU0708995401.HKD","LU2471134879.HKD","IE00BK4W5L77.USD","BK4139","LU2361045086.USD","LU2462157665.USD","LU0109391861.USD","LU2491050071.SGD","HRTS","LU1868836914.USD","LU1720051108.HKD","IE00BJLML261.HKD","SG9999018865.SGD","IE0005OL40V9.USD","LU2023250504.SGD","LU0354030511.USD","IHE","LU0345770993.USD","LU2106854487.HKD","SG9999001176.SGD","IBBQ","LU0432979614.USD","IE00BKDWB100.SGD","LU2089284900.SGD","BK4599","IE00B2B36J28.USD","IYH","LU0787776722.HKD","LU0882574139.USD","SG9999015978.USD","LU0208291251.USD","LU0256863902.USD","LU0320765489.SGD","LU0820561818.USD","BK4533","LU2461242641.AUD","LLYX","BIB","IE0004445239.USD","IE00BJJMRZ35.SGD","LU2089283258.USD","LU2491050154.USD","SG9999014880.SGD","SG9999001176.USD","SG9999015952.SGD","LU0070302665.USD","LU2746668461.USD","LU1267930730.SGD","ILDR","XLV","LU1983299246.USD","LU2168564222.USD","BK4566","LU2213496289.HKD","IXJ","LU0689472784.USD","IE00BJJMRY28.SGD","LU1712237335.SGD","LU0109394709.USD","LU1804176565.USD","NVOH","LU0238689110.USD","IE00B4R5TH58.HKD","LU0122379950.USD","LU0211331839.USD","LU0471298777.SGD","LU1093756325.SGD","CANC","LU1035775433.USD","SGXZ51526630.SGD","SGXZ99366536.SGD","LU2265009873.SGD","CURE","LU1093756168.USD","LU0006306889.USD","SGXZ57979304.SGD","LU2237443978.SGD","LU0786609619.USD","LU0198837287.USD","LU1917777945.USD","LU2357305700.SGD","SG9999013999.USD","LU2471134523.USD","TRUH","BK4588","RXL","LU1232071149.USD","LU2552382058.USD","PJP","LU0096364046.USD","LU2417539215.USD","LU2896262040.SGD","LU2211815571.USD","SG9999017495.SGD","LU1571399168.USD","LU0823434583.USD","LU1974910355.USD","IE00B4JS1V06.HKD","LU0133085943.USD","LU1988902786.USD","BK4581","MEDI","LU1280957306.USD","MHIP","LU2242652126.USD","IE00B1BXHZ80.USD","FHLC","LU2112291526.USD","IE00BFSS8Q28.SGD","PPH","SG9999014914.USD","LU0266013472.USD","LU0820562030.AUD","LU2471134796.USD","LU0417517546.SGD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU1979441026.SGD","LU2602419157.SGD","NVOC","LU0154236417.USD","LU0354030438.USD","LLYZ","AMGN","LU0964807845.USD","IE00BK4W5M84.HKD","LU0158827781.USD","LU1551013425.SGD","LU0889565916.HKD","LU2756315318.SGD","GB00BDT5M118.USD","LLY","LU2237438978.USD","OZEM","LU0823416689.USD","LU0058720904.USD","LU1868837136.USD","FTXH","LU0320765992.SGD","LU0820561909.HKD","GDOC","LU2271345857.HKD","LU0882574055.USD","SGXZ31699556.SGD","LU1069344957.HKD","LU2087625088.SGD","IE00BFTCPJ56.SGD","LU0158827948.USD","LU0345770308.USD","ELIS","IE0002141913.USD","LU2361044949.HKD","LU2462591350.SGD","IBB","LU0672654240.SGD","LU1323610961.USD","LU2023250330.USD","LU2552382132.HKD","LU0256863811.USD","LU0289739699.SGD","LU2108987350.USD","LU0094547139.USD","LU0234572021.USD","IE00BJT1NW94.SGD","IE00B775H168.HKD","LU1623119135.USD","LU2264538146.SGD","IE00BKPKM429.USD","LU1629891620.HKD","LU0353189763.USD","LU2168563687.JPY","WDNA","LU0097036916.USD","LU1366192091.USD","LU2168564149.EUR","LU2023251221.USD","IE00BJJMRX11.SGD","BK4007","IE0009355771.USD","LU0640476718.USD","LU2236285917.USD","SG9999014906.USD","TBXU","BK4532","LU0203202063.USD","LU2242646821.SGD","LU1814569148.SGD","IE0004445015.USD","LU1720051017.SGD","LU2028103732.USD","SGXZ81514606.USD","BK4516","LU2089984988.USD","SG9999015986.USD","IE00BN29S564.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666506002","title":"Palo Alto, Eaton, Amgen, SpaceX, LMT Trending With Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2666506002","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666506002?lang=en_us&edition=fundamental","pubTime":"2026-09-12 17:01","pubTimestamp":1789203667,"startTime":"0","endTime":"0","summary":"Analysts are intrested in these 5 stocks: ( ($PANW) ), ( ($ETN) ), ( ($AMGN) ), ( ($SPCX) ) and ( ($LMT) ). Here is a breakdown of their recent","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/palo-alto-eaton-amgen-spacex-lmt-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/palo-alto-eaton-amgen-spacex-lmt-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBH","IBB","LU0889565916.HKD","LOFF","SPCM","IDEF","NATO","ELOL","SPAL","LMTS","TBXU","DIPR","PBE","SNK","UFO","SPCH","SHLD","SPAX","FOWF","YSPC","LOFD","LU1162221912.USD","SPCX","SSPC","LU1861559042.SGD","WSPC","MISL","AMGN","BK4516","XOVL","ORBX","SPCF","LMTL","SPCU","SPCG","LMT","WDGF","IBBQ","MARS","SPCQ","XOVR","LU1861220033.SGD","LU1244550577.SGD","LU1861558580.USD","WARP","PJP","BIB","DSPC","DXYZ","PPA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666577803","title":"Scholar Rock announces FDA approval of isembyld","url":"https://stock-news.laohu8.com/highlight/detail?id=2666577803","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666577803?lang=en_us&edition=fundamental","pubTime":"2026-09-12 06:30","pubTimestamp":1789165818,"startTime":"0","endTime":"0","summary":"Scholar Rock (SRRK) announced that the FDA has approved isembyld for the treatment of spinal muscular atrophy in adults and children two years of a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","THNR","BBP","MRNY","LFSC","IEIH","RSPH","IBB","GDOC","BK4588","TBXU","MRNX","IBRN","LABU","SYNB","BMED","PSCH","SRRK","NVIB","MEDI","TECB","GNMX","BK4139","FRTY","IYH","XLVX","IDNA","PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666574557","title":"Amgen Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666574557","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666574557?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:35","pubTimestamp":1789158900,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  shed 1.34% to $377.35 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.86% to 7,656.98 and the Dow Jones Industrial Average  rising 0.98% to 52,573.29.This was the stock's fifth consecutive day of losses.Amgen Inc. closed 15.59% below its 52-week high of $447.03, which the company achieved on August 25th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  fell 0.29% to $265.58, Pfizer Inc.  rose 0.25% to $27.72, and AbbVie Inc.  rose 0.83% to $257.12.Trading volume  remained 337,805 below its 50-day average volume of 2.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 11, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","BK4534","BK4533","BIB","LU1057294990.SGD","PBE","SG9999001440.SGD","IBB","IE00BJJMRZ35.SGD","BK4139","IE00B4R5TH58.HKD","BK4585","PJP","IE00BFTCPJ56.SGD","BK4588","LU0868494617.USD","LU1061106388.HKD","LU1571399168.USD","LU1983299246.USD","LU2112291526.USD","TBXU","LU0122379950.USD","LU0289739699.SGD","BK4581","BBH","LU1023059063.AUD","LU2242652126.USD","IE0002141913.USD","LU0320765992.SGD","LU0889565916.HKD","LU2242646821.SGD","IBBQ","LU0109394709.USD","LU0058720904.USD","BK4599","AMGN","04332","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU2089984988.USD","BK4566","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}